🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 71722W107
- Market Cap
- Mid Cap
- IPO
- 10/25/2019 · $19.00/share
Business: Phathom Pharmaceuticals, Inc. is a late clinical-stage biopharmaceutical company committed to transforming the treatment landscape for people suffering from gastrointestinal (GI) diseases related to acid.
Company Contact
- CEO
- Terrie Curran
- CFO
- Molly Henderson
- Headquarters
- 100 Campus Drive, Suite 102, Florham Park, NJ 07932
- Phone
- 877-742-8466
- Investor Relations
- 650-325-5156 · info@phathompharma.com